RAS Mutation in Acute Myeloid Leukemia Is Associated With Distinct Cytogenetic Subgroups but Does Not Influence Outcome in Patients Younger Than 60 Years

Blood - United States
doi 10.1182/blood-2005-03-0867
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Acute Myeloid Leukemia in Patients Older Than 60 Year

Journal of Tumor Medicine & Prevention
2018English

NPM1 Mutation Is Associated With Leukemia Cutis in Acute Myeloid Leukemia With Monocytic Features

Haematologica
Hematology
2015English

Cytogenetic Heterogeneity Negatively Impacts Outcomes in Patients With Acute Myeloid Leukemia

Haematologica
Hematology
2014English

RAS Mutation Is Associated With Hyperdiploidy and Parental Characteristics in Pediatric Acute Lymphoblastic Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2005English

Upregulation of the EMT Marker Vimentin Is Associated With Poor Clinical Outcome in Acute Myeloid Leukemia

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

DNMT3A Mutation Is Associated With Increased Age and Adverse Outcome in Adult T-Acute Lymphoblastic Leukemia

Haematologica
Hematology
2019English

Intensive Consolidation With G-CSF Support: Tolerability, Safety, Reduced Hospitalization, and Efficacy in Acute Myeloid Leukemia Patients ≥60 Years

American Journal of Hematology
Hematology
2017English

Mutation Analysis of the Transcription Factor PU.1 in Younger Adults (16 to 60 Years) With Acute Myeloid Leukemia: A Study of the AML Study Group Ulm (AMLSG ULM)

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Allogeneic NK Cells Eradicate Myeloblasts but Not Neoplastic Mast Cells in Systemic Mastocytosis Associated With Acute Myeloid Leukemia

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy